v3.25.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Dialysis patient service revenues $ 13,007,186 $ 12,260,375 $ 11,574,941
Other revenues 635,883 555,175 565,206
Total revenues 13,643,069 12,815,550 12,140,147
Operating expenses:      
Patient care costs 9,243,476 8,598,521 8,319,717
General and administrative 1,673,630 1,538,341 1,473,984
Depreciation and amortization 715,348 723,860 745,443
Equity investment income, net (33,000) (26,189) (27,864)
Goodwill impairment charges 0 0 26,083
Gain on changes in ownership interests 0 (109,466) 0
Total operating expenses 11,599,454 10,725,067 10,537,363
Operating income 2,043,615 2,090,483 1,602,784
Debt expense (579,926) (470,469) (398,551)
Debt extinguishment and modification costs (14,178) (19,813) (7,962)
Other loss, net (102,688) (69,808) (19,177)
Income from continuing operations before income taxes 1,346,823 1,530,393 1,177,094
Income tax expense 293,107 279,656 220,116
Net income from continuing operations 1,053,716 1,250,737 956,978
Net income from discontinued operations, net of tax 25,000 0 0
Net income 1,078,716 1,250,737 956,978
Less: Net income attributable to noncontrolling interests (331,913) (314,395) (265,443)
Net income attributable to DaVita Inc. $ 746,803 $ 936,342 $ 691,535
Earnings per share attributable to DaVita Inc.:      
Basic net income from continuing operations $ 9.72 $ 11.02 $ 7.62
Basic net income 10.06 11.02 7.62
Diluted net income from continuing operations 9.51 10.73 7.42
Diluted net income $ 9.84 $ 10.73 $ 7.42
Weighted average shares for earnings per share:      
Basic shares (in shares) 74,227,000 84,991,000 90,790,000
Diluted shares (in shares) 75,885,000 87,274,000 93,182,000
Amounts attributable to DaVita Inc.:      
Net income from continuing operations $ 721,803 $ 936,342 $ 691,535
Net income from discontinued operations 25,000 0 0
Net income attributable to DaVita Inc. $ 746,803 $ 936,342 $ 691,535